MYRF: Myelin Regulatory Factor

A key transcription factor for central nervous system myelination and oligodendrocyte differentiation

Gene Information Card

Symbol MYRF
Full Name Myelin Regulatory Factor
Gene Type Protein coding
Chromosomal Location 11q12.2
NCBI Gene ID 745 ncbi.nlm.nih.gov/gene/745
Ensembl ID ENSG00000149257
UniProt ID Q9Y2G1
OMIM ID 608329
HGNC ID 7581
Aliases C11orf9, MRF, Ndt80, TMEM98

Description

MYRF (myelin regulatory factor) is a transcription factor essential for the development and maintenance of myelin in the central nervous system. It regulates the expression of myelin-related genes in oligodendrocytes and is critical for oligodendrocyte differentiation and myelination. Mutations in MYRF are associated with hypomyelinating leukodystrophy and congenital cataract.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Hypomyelinating leukodystrophy 11 (HLD11) Loss-of-function mutations impair oligodendrocyte differentiation and myelin production, leading to CNS hypomyelination. ClinVar, OMIM
Congenital cataract, with or without microcornea Dominant-negative or missense mutations disrupt MYRF function in lens development, causing cataract formation. ClinVar, OMIM
Myelination disorder, autosomal recessive Biallelic loss-of-function variants result in severe hypomyelination and neurological deficits. ClinVar

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 15.2 High
Spinal cord 12.8 High
Optic nerve 10.5 High
Testis 3.1 Medium
Lung 0.8 Low
Cell Line Expression
Cell Line nTPM Notes
Oligodendrocytes (primary) 25.0 High expression; key cell type for MYRF function
MO3.13 (oligodendrocyte precursor) 18.5 Moderate expression; increases upon differentiation
SH-SY5Y (neuroblastoma) 0.5 Low expression
HEK293 (embryonic kidney) 0.2 Very low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1603C>T (p.Arg535*) Nonsense Rare Loss of function; truncation of C-terminal domain
c.1996G>A (p.Gly666Arg) Missense Rare Dominant-negative effect; disrupts DNA binding
c.2269_2270del (p.Gln757fs) Frameshift Rare Loss of function; premature termination
c.1A>G (p.Met1?) Start loss Rare Complete loss of protein expression
Mutation functional classification

Loss of Function (LOF)

Nonsense, frameshift, and start-loss mutations that reduce or abolish MYRF protein expression or function, leading to hypomyelination.

Gain of Function (GOF)

Not reported for MYRF; no activating mutations described.

Dominant Negative (DN)

Missense mutations (e.g., p.Gly666Arg) that interfere with wild-type MYRF function, often associated with congenital cataract.

Pathways

Oligodendrocyte differentiation and myelination (Reactome: R-HSA-9617324)
Transcriptional regulation of myelin genes (KEGG: map04510)

Protein Summary

MYRF is a 1,149-amino-acid transcription factor containing an N-terminal DNA-binding domain (DBD) with a conserved Ndt80-like domain, a central coiled-coil region, and a C-terminal transcriptional activation domain. It forms homotrimers and binds to specific promoter elements of myelin-related genes such as MBP, PLP1, and MAG. MYRF is synthesized as a transmembrane precursor that undergoes autocatalytic cleavage to release the N-terminal fragment, which translocates to the nucleus to activate transcription. Its expression is highly enriched in oligodendrocytes and is essential for CNS myelination.

Related Products

Product name Cat.No. Species Gene ID
MYRF Knockout HEK293 Cell Line EDJ-KQ1012 Human 745 Details Get a Quote
MYRFL Knockout HEK293 Cell Line EDJ-KQ11558 Human 196446 Details Get a Quote
MYRF Knockout A-549 Cell Line EDJ-KQ20077 Human 745 Details Get a Quote
MYRF Knockout HCT 116 Cell Line EDJ-KQ20078 Human 745 Details Get a Quote
MYRF Knockout HeLa Cell Line EDJ-KQ20079 Human 745 Details Get a Quote
Displaying Records 1 To 5 Of 5 Records
Contact Us
*
*
*
*
How did you hear about us: